Etiotropic therapy of the new coronavirus infection. Expectations and realities. Part 2
Author(s) -
Olga Yu. Kuznetsova
Publication year - 2022
Publication title -
russian family doctor
Language(s) - English
Resource type - Journals
eISSN - 2713-2331
pISSN - 2072-1668
DOI - 10.17816/rfd108485
Subject(s) - ritonavir , coronavirus , medicine , drug , placebo , clinical trial , monoclonal antibody , virology , intensive care medicine , covid-19 , pharmacotherapy , randomized controlled trial , protease inhibitor (pharmacology) , drug trial , immunology , viral load , pharmacology , virus , alternative medicine , antibody , pathology , disease , antiretroviral therapy , infectious disease (medical specialty)
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom